Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours
10.1136/jclinpath-2011-200082
Saved in:
Main Authors: | Yan, B., Choo, S.N., Mulyadi, P., Srivastava, S., Ong, C.W., Yong, K.J., Putti, T., Salto-Tellez, M., Lim, G.S.D. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/109309 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Dual-colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples
by: Yan, B., et al.
Published: (2014) -
HER2 expression in breast cancer with nonamplified HER2 and gains of chromosome 17 centromere
by: Ravat Panvichian, et al.
Published: (2018) -
Molecular dynamics simulations of asymmetric heterodimers of HER1/HER2 complexes
by: Chonticha Suwattanasophon, et al.
Published: (2019) -
Proteomics of breast cancer: enhanced expression of CK19 in HER-2/neu-positive tumours.
by: Tai, L.K., et al.
Published: (2016) -
Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib : implications for the treatment of HER2-positive and HER2-mutated breast cancer
by: Collins, Denis M., et al.
Published: (2020)